Station South Development
Sector: Road • Location: Huntersville, North Carolina, United States
Source: The Business Journals
The Station South project in Huntersville aims to rezone a 21.3-acre site for a mixed-use development that includes 348 residential units and approximately 25,000 square feet of commercial space, including restaurants, retail, and offices. This development is strategically located near the proposed Red Line commuter rail station.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | The Station South project in Huntersville aims to rezone a 21.3-acre site for a mixed-use development that includes 348 residential units and approximately 25,000 square feet of commercial space, including restaurants, retail, and offices. This development is strategically located near the proposed Red Line commuter rail station. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Road projects in United States
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Morphotek’s New Biologics Production Facility
- LabCentral 238, Cambridge, Massachusetts, USA
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US
- Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
- Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina
- Vertex Pharmaceuticals’ Boston Campus
- Roche Diagnostics PCR Diagnostic Kits
